Home > Healthcare > Medical Devices > Diagnostic Devices > Arbovirus Testing Market

Arbovirus Testing Market Trends

  • Report ID: GMI5950
  • Published Date: Jun 2023
  • Report Format: PDF

Arbovirus Testing Market Trends

The rising incidence of arbovirus infections such as dengue fever and zika virus infection due to climate change, urbanization and global travel are some of the major factors further augmenting the market expansion. For instance, according to the World Health Organization (WHO), 50-100 million cases of dengue fever, 500,000 cases of dengue haemorrhagic fever/ dengue shock syndrome and more than 20 000 deaths occur each year. This rise in arbovirus infections creating demand for accurate and timely diagnostic testing to facilitate early detection and appropriate patient management.
 

The surge in arbovirus cases leads to increasing focus on surveillance, prevention, and control measures, this will further accelerate the need for reliable and efficient arbovirus testing solutions. As a result, the market will experience substantial growth with advancements in diagnostic technologies and the development of new testing methods to meet the rising demand.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for arbovirus testing was valued at more than USD 1 billion in 2022 and is projected to reach over USD 1.9 billion by 2032, backed by the growing need for accurate & timely diagnosis of arbovirus infections to guide appropriate patient management and public health interventions.

The ELISA-based tests segment accounted for more than USD 530 million in 2022, attributable to several innovations and continuous improvements in assay design, sensitivity, and specificity including development of multiplex ELISA assays for enhanced diagnostic efficiency and cost-effectiveness.

The U.S. arbovirus testing industry accounted for over USD 400 million in 2022 and will witness substantial growth over 2023-2032, owing to the surge in incidence of arbovirus diseases and booming geriatric population that are highly prone to viral diseases.

Agilent Technologies Inc., Thermo Fisher Scientific, NovaTec Immundiagnostica GmbH, Euroimmun AG, Abbott Laboratories, DiaSorin SpA, Distek, Becton, Dickinson and Company, Merck KGaA, F. Hoffmann La Roche Ltd., Siemens Healthineers AG, and QIAGEN N.V. among others.

Arbovirus Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 192
  • Countries covered: 30
  • Pages: 146
 Download Free Sample